FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-9322com.
(The FASEB Journal. 2008;22:671-681.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-9322comv1
22/3/671    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maynadier, M.
Right arrow Articles by Garcia, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maynadier, M.
Right arrow Articles by Garcia, M.
(The FASEB Journal. 2008;22:671-681.)
© 2008 FASEB

Unliganded estrogen receptor {alpha} inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1)

Marie Maynadier*,{dagger},1, Jean-Marie Ramirez*,{dagger},1, Anne-Marie Cathiard*,{dagger}, Nadine Platet*,{dagger}, Delphine Gras*,{dagger}, Michel Gleizes{dagger}, M. Saeed Sheikh{ddagger}, Philippe Nirde*,{dagger} and Marcel Garcia*,{dagger},2

* INSERM, Unité 826, Montpellier, France;

{dagger} University of Montpellier 1, Montpellier, France; and

{ddagger} Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York, USA

2Correspondence: INSERM Unité 826, CRLC, 208 rue des Apothicaires, 34298 Montpellier Cedex 1, France. E-mail: marcel.garcia{at}valdorel.fnclcc.fr

Estrogens are mitogenic in human breast cancer cells, but the presence of estrogen receptor {alpha} (ER{alpha}) is associated with a favorable prognosis in primary tumors and the molecular basis for this paradoxical relationship remains unknown. Here we show that ER{alpha} and ER{alpha} mutants devoid of ligand and DNA-binding domains inhibit cell growth in three-dimensional matrix as well as tumor formation in nude mice. Using in vitro and intracellular approaches, we have found that ER{alpha}, via its amino acids 184–283, interacts with cyclin-dependent kinase inhibitor p21WAF1. Both proteins exhibit mutual interactions in the absence of estrogens or in the presence of pure antiestrogen ICI182,780, whereas estradiol treatment disrupts their interactions. Cross-linking experiments reveal that these proteins are present in a larger complex of ~200 kDa that also contains cdk2 and cyclin E. We further demonstrate that the unliganded full-length ER{alpha} or the variant having the p21WAF1 interaction region significantly increases p21WAF1 expression, whereas ER{alpha} silencing reduces p21WAF1 levels and silencing of p21WAF1 is sufficient to prevent ER{alpha}-induced growth inhibition. Taken together, our results point to an antiproliferative function of the unliganded ER{alpha} through its physical interactions with p21WAF1 that may also explain the favorable prognosis of ER{alpha}-positive breast cancers.—Maynadier, M., Ramirez, J.-M., Cathiard, A.-M., Platet, N., Gras, D., Gleizes, M., Sheikh, M. S., Nirde, P., Garcia, M. Unliganded estrogen receptor alpha inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1).


Key Words: cell cycle • steroid • proliferation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.